CVKDCadrenal Therapeutics, Inc. · Nasdaq Capital Market
Effective Supply — the real overhang

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

2.64M
Reported Float
2.55M
Tradeable Now
(estimated float)
3.72M
Effective Supply
8.45M
Fully Diluted
Dilution risk8/10
CONFIDENCE: MEDIUM
HIGHAssessed Jul 21, 2026Trigger: EFFECT registration filingCRITICALPre-funded warrant overhang (economically issued stock outside the float)HIGHRecently registered shares now free-trading

The dominant, actionable mechanism is 960,000 pre-funded warrants at $0.0001 held by Armistice Capital, resale-registered and effective as of 2026-07-20, cashless-exercisable with only a 9.99% blocker gating the pace. That is 38% of the ~2.55M tradeable float in supply that requires zero further company action and no capital outlay to reach the tape — the functional equivalent of a fully paid, registered secondary sitting on the bid. Add 62,400 PA warrants at $3.9063 and the entirety of the C/B warrant stack ($3.00 and $4.50 strikes) sitting out of the money against a $2.09 print, plus an ATM that reopens 60 days after the July effectiveness. Offsetting factors that hold this off a 9-10: there are NO convertible notes, NO preferred outstanding, and NO variable-rate or reset mechanics anywhere in the structure (the PIPE expressly bars variable-rate transactions for one year), so the OTM warrants cannot ratchet down into the money. Issuance cadence has nonetheless been relentless — ATM drip, December 2025 registered direct, April 2026 inducement, July 2026 PIPE — with shares outstanding up 14.4% in the six weeks from 2026-03-27 to 2026-05-06 alone.

Share Structure

Float to Fully Diluted Breakdown

LIKELY STALE

Reported float from Insight Sentry (NASDAQ:CVKD), as-of date unknown. Adjusted based on SEC filing analysis.

Reported Float2.64M31.2%
Warrants4.60M54.4%
pre-funded960K shares at $0.0001
common960K shares at $3
common960K shares at $3
common571K shares at $4.5
common571K shares at $4.5
placement_agent62K shares at $3.9063
placement_agent37K shares at $5.625
placement_agent13K shares at $13.5625
common415K shares at $10.6
placement_agent19K shares at $20.625
placement_agent19K shares at $32.81
placement_agent6K shares at $90
placement_agent1K shares at $15
placement_agent767 shares at $45
Options / RSUs403K4.8%
Stock Options403K shares
≈ Estimated Actual Float

Reported float + filing adjustments

2.55M

MEDIUM confidence

Pending Shares as % of Float199.9%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted8.45M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits
  • 1-for-15·Aug 20, 2024~2 yr ago
Active mechanisms
  • 960,000 pre-funded warrants at $0.0001, resale-registered effective 2026-07-20, cashless-exercisable, 9.99% blocker — functionally free-trading stock
  • 1,920,000 Series C-1/C-2 warrants at $3.00 (C-2 immediately exercisable; C-1 requires stockholder approval)
  • 1,142,860 Series B-1/B-2 warrants at $4.50, registered and exercisable
  • ATM facility with H.C. Wainwright (3.0% commission) — resumes 60 days after the 2026-07-20 effective date
  • 414,748 December 2025 investor warrants at $10.60
  • 403,000 options plus 264,587 shares available under the 2022 Plan, with a 20%-of-outstanding annual evergreen
  • Repeat warrant-inducement mechanic: strikes repriced downward twice ($26.25 to $16.50 to $4.50), each time generating a fresh double tranche of new warrants

Market Data

Price

$2.04

Market Cap

$6.32M

Outstanding

3.10M

Float

2.64M

Avg Volume

89.7K

Exchange: NASDAQ|Source: Insight Sentry